Global POC HIV Testing Market Size By Type (Testing Equipment, Testing Reagent), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Point-of-Care (POC) HIV Testing Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2031, expanding at a compound annual growth rate (CAGR) of 9.1% during the forecast period from 2023 to 2031. The rapid growth of this market is attributed to increasing global efforts toward early HIV detection, rising prevalence of HIV infections, and an increasing preference for decentralized, accessible diagnostic solutions. POC HIV testing offers rapid results, allowing for immediate clinical decisions, which is particularly vital in low-resource settings and for at-risk populations.

Drivers:

1. Rising Prevalence of HIV Infections:

The increasing number of HIV-positive individuals worldwide is fueling the need for fast, accurate, and accessible testing solutions. According to UNAIDS, over 38 million people globally are living with HIV, necessitating widespread testing.

2. Increased Global Health Initiatives:

Governmental and non-governmental organizations are actively promoting early HIV detection through mass screening programs, especially in Africa, Asia-Pacific, and Latin America.

3. Technological Advancements in POC Diagnostics:

The emergence of advanced lateral flow assays and molecular POC platforms with higher sensitivity and specificity is accelerating the market.

Restraints:

1. Variability in Regulatory Approvals:

Inconsistent regulatory frameworks across countries and regions can delay product approvals and market entry, particularly for new and innovative POC testing devices.

2. Limited Awareness in Remote Areas:

Inadequate healthcare awareness and social stigma associated with HIV still hinder testing uptake, particularly in rural and underdeveloped regions.

Opportunity:

1. Expansion in Emerging Economies:

Countries in Asia-Pacific and Sub-Saharan Africa offer immense growth opportunities due to high HIV incidence rates and unmet diagnostic needs.

2. Integration with Mobile Health (mHealth):

Smartphone-linked diagnostics and digital health integration for result sharing and patient monitoring present a scalable growth frontier.

Market by System Type Insights:

Based on system type, the Antibody-based POC Test segment held the largest market share in 2023. These tests are widely adopted due to their ease of use, cost-effectiveness, and rapid turnaround time. However, the Molecular-based POC Test segment is projected to grow at the fastest pace, driven by the rising demand for early-stage and accurate viral detection.

Market by End-use Insights:

By end use, the Hospitals & Clinics segment dominated the market in 2023, benefiting from structured workflows and immediate follow-up care. The Community Health Centers segment is expected to witness the highest growth during the forecast period due to focused outreach and government-supported awareness programs in resource-limited settings.

Market by Regional Insights:

North America led the global POC HIV testing market in 2023, supported by high healthcare expenditure, advanced diagnostic infrastructure, and active screening policies. Meanwhile, Asia-Pacific is expected to register the highest CAGR during the forecast period, spurred by growing HIV prevalence, international aid, and increasing access to healthcare services in countries like India, China, and Thailand.

Competitive Scenario:

Key players in the market include Abbott Laboratories, Bio-Rad Laboratories, Chembio Diagnostics, OraSure Technologies, bioMérieux, F. Hoffmann-La Roche AG, Siemens Healthineers, and Trinity Biotech. These companies are focusing on enhancing product performance, entering strategic partnerships, and expanding their geographic reach.

Key Market Developments:

In 2023, OraSure Technologies launched an upgraded version of its OraQuick HIV Self-Test with improved digital result interpretation via mobile applications.

Abbott introduced a smartphone-integrated lateral flow POC HIV diagnostic tool in 2024 for remote and decentralized testing environments.

Chembio Diagnostics entered a partnership with a major African healthcare NGO in 2025 to distribute rapid HIV test kits across Sub-Saharan Africa.

Scope of Work – Global POC HIV Testing Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.4 billion

CAGR (2023–2031) 9.1%

Market Segments System Type, End-use, Region

Growth Drivers Rising HIV prevalence, Global health initiatives, Technological advancements

Opportunities Emerging market expansion, Mobile-integrated diagnostics

FAQs

1) What is the current market size of the Global POC HIV Testing Market?

The Global POC HIV Testing Market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global POC HIV Testing Market?

The major growth drivers include rising HIV prevalence and global health initiatives promoting early detection.

3) Which is the largest region during the forecast period in the Global POC HIV Testing Market?

North America held the largest market share in 2023, though Asia-Pacific is anticipated to witness the highest growth.

4) Which segment accounted for the largest market share in the Global POC HIV Testing Market?

The Antibody-based POC Test segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global POC HIV Testing Market?

Key players include Abbott Laboratories, Chembio Diagnostics, OraSure Technologies, Roche, Siemens Healthineers, and bioMérieux.